IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Int J Mol Sci. 2021 Dec 22;23(1):90. doi: 10.3390/ijms23010090.
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression at the post-transcriptional level and that play an important role in many cellular processes, including modulation of inflammation. MiRNAs are present in high concentrations in the central nervous system (CNS) and are spatially and temporally expressed in a specific way. Therefore, an imbalance in the expression pattern of these small molecules can be involved in the development of neurological diseases. Generally, CNS responds to damage or disease through the activation of an inflammatory response, but many neurological disorders are characterized by uncontrolled neuroinflammation. Many studies support the involvement of miRNAs in the activation or inhibition of inflammatory signaling and in the promotion of uncontrolled neuroinflammation with pathological consequences. MiR-155 is a pro-inflammatory mediator of the CNS and plays an important regulatory role. The purpose of this review is to summarize how miR-155 is regulated and the pathological consequences of its deregulation during neuroinflammatory disorders, including multiple sclerosis, Alzheimer's disease and other neuroinflammatory disorders. Modulation of miRNAs' expression could be used as a therapeutic strategy in the treatment of pathological neuroinflammation.
微小 RNA(miRNA)是一种小的非编码 RNA 分子,可在转录后水平调节基因表达,在包括炎症调节在内的许多细胞过程中发挥重要作用。miRNA 在中枢神经系统(CNS)中浓度较高,并以特定的时空方式表达。因此,这些小分子表达模式的失衡可能与神经疾病的发展有关。通常,CNS 通过炎症反应的激活来应对损伤或疾病,但许多神经疾病的特点是不受控制的神经炎症。许多研究支持 miRNA 参与炎症信号的激活或抑制以及促进具有病理后果的不受控制的神经炎症。miR-155 是 CNS 的促炎介质,发挥着重要的调节作用。本综述的目的是总结 miR-155 的调控方式及其在神经炎症性疾病(包括多发性硬化症、阿尔茨海默病和其他神经炎症性疾病)中的失调所产生的病理后果。调节 miRNA 的表达可作为治疗病理性神经炎症的一种治疗策略。